AbbVie, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
3,716.00
6,250.00
13,477.00
12,989.00
3,398.00
8,426.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-2,782.00
2,813.00
-258.00
-1,322.00
106.00
-1,329.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
18,806.00
22,801.00
24,943.00
22,777.00
17,588.00
13,324.00
Cash Flow from Investing Activities
-20,820.00
-2,009.00
-623.00
-2,344.00
-37,557.00
596.00
Cash Flow from Financing Activities
-5,211.00
-17,184.00
-24,803.00
-19,039.00
-11,501.00
18,708.00
Net Cash Inflow / Outflow
-7,290.00
3,613.00
-545.00
1,297.00
-31,475.00
32,635.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-65.00
5.00
-62.00
-97.00
-5.00
7.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of AbbVie, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
3716
16687
-12,971.00
-77.73%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-2782
1837
-4,619.00
-251.44%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
18806
24266
-5,460.00
-22.50%
Cash Flow from Investing Activities
-20820
-18599
-2,221.00
-11.94%
Cash Flow from Financing Activities
-5211
-3132
-2,079.00
-66.38%
Net Cash Inflow / Outflow
-7290
2246
-9,536.00
-424.58%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-65
-289
224.00
77.51%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -17.52% vs -8.59% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
18,806.00
22,801.00
-17.52%






